AFMBX
Price
$37.81
Change
+$0.24 (+0.64%)
Updated
Sep 4 closing price
Net Assets
257.73B
RLBFX
Price
$38.08
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

AFMBX vs RLBFX

Header iconAFMBX vs RLBFX Comparison
Open Charts AFMBX vs RLBFXBanner chart's image
American Funds American Balanced F3
Price$37.81
Change+$0.24 (+0.64%)
VolumeN/A
Net Assets257.73B
American Funds American Balanced R5
Price$38.08
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
AFMBX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AFMBX vs. RLBFX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFMBX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AFMBX (258B) and RLBFX (258B) have equal amount of cash in the bank . AFMBX (2.10) and RLBFX (2.05) have matching dividends . AFMBX was incepted earlier than RLBFX: AFMBX (9 years) vs RLBFX (23 years). RLBFX (0.29) is less costly to investors than AFMBX (0.25). AFMBX (44.00) and RLBFX (44.00) have comparable annual turnover. RLBFX has a lower initial minimum investment than AFMBX: RLBFX (250) vs AFMBX (1000000). RLBFX annual gain was more profitable for investors over the last year : 10.28 vs. AFMBX (9.75). RLBFX (41.46) and AFMBX (41.01) have equivalent 5 years return.
AFMBXRLBFXAFMBX / RLBFX
Total Expense Ratio0.250.2986%
Annual Report Gross Expense Ratio0.250.2986%
Fund Existence9 years23 years-
Gain YTD11.02711.56295%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets258B258B100%
Annual Yield % from dividends2.102.05102%
Returns for 1 year9.7510.2895%
Returns for 3 years40.3640.9299%
Returns for 5 years41.0141.4699%
Returns for 10 yearsN/A78.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EWTX15.570.95
+6.50%
Edgewise Therapeutics
BTAI3.790.22
+6.16%
BioXcel Therapeutics Inc
ATMCU12.65N/A
N/A
AlphaTime Acquisition Corp
RRC34.70-0.24
-0.69%
Range Resources Corp
KOPN2.12-0.02
-0.93%
Kopin Corp